abstract |
To provide a stable liquid preparation containing human growth hormone. Since human growth hormone in the formulation tends to be unstable, L-lysine, L-arginine, or polyethylene glycol 300; and poly (oxyethylene) poly ( Liquid formulation containing oxypropylene) copolymer, polyethylene glycol-15 polyoxystearate or polyethylene glycol-35 castor oil. [Selection figure] None |